Company Summary
Search
Home Page
 
*Immunovaccine Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
December 31DelistN
Board of Directors
NamePosition
(not available)
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
18/May/2007 25/Nov/2014 Canada   
Exchange Filing Office
Location
(not available)
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  *Research and Development in the Physical, Engineering and Life Sciences  News Release June 11, 2014-Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company's DepoVax? platform, a patented formulation that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Immunovaccine has advanced two T cell activation therapies for cancer through Phase I human clinical trials. Lead cancer vaccine therapy, DPX-Survivac, is expected to enter Phase II clinical studies in both ovarian cancer and glioblastoma (brain cancer). The Company is also advancing an infectious disease pipeline including innovative vaccines for respiratory syncytial virus (RSV) and anthrax. 
  *Capital Pool Company  (not available) 
Securities
SymbolSecurity NameMarketStatus
*IMV*Immunovaccine Inc.TSX VentureDELIST
*RHI.P*Rhino Resources Inc.TSX VentureDELIST
Name HistoryFromTo
*Immunovaccine Inc.5/Oct/200925/Nov/2014
*Rhino Resources Inc.19/Jun/20074/Oct/2009
Company Facts Reconciliation
SubjectDate Returned
Fall 2014 CFRNot Received
Associations
Auditing Firm:  *PricewaterhouseCoopers LLP
Sponsor:  *Macquarie Private Wealth Inc.
Transfer Agent:  *Computershare Investor Services Inc.
  *Computershare Trust Company of Canada
Latest Information
TypeDateTitle
News Releases  24/Nov/2014  NEWS RELEASE - IMMUNOVACCINE RECEIVES FINAL APPROVAL TO GRADUATE TO TSX[MARKETWIRE]
    NEWS RELEASE - HEALTH CANADA CLEARS IMMUNOVACCINE TO CONDUCT PH[MARKET NEWS]
    NEWS RELEASE - HEALTH CANADA CLEARS IMMUNOVACCINE TO CONDUCT PHASE II CLINICAL TRIAL OF DPX-SURVIVAC IN RECURRENT LYMPHOMA[MARKETWIRE]
Bulletins  25/Nov/2014  Delist
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data